Yingying Kang

机构：Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University

发表论文 34 篇 · 总被引 414 次 · h-index 11

代表论文

• 2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response (2022 · Bioorganic Chemistry · 被引 22)
• An umbrella review of Lianhua Qingwen combined with Western medicine for the treatment of coronavirus disease 2019 (2022 · Acupuncture and Herbal Medicine · 被引 14)
• Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors (2022 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 14)
• Synthesis of ZSM‐5 by hydrothermal method with pre‐mixing in a stirred‐tank reactor (2019 · The Canadian Journal of Chemical Engineering · 被引 13)
• Production of ZSM-5 zeolites using rotating packed bed: Impact mechanism and process synthesis studies (2021 · Chemical Engineering Science · 被引 11)
• Design, synthesis, and biological activity evaluation of novel tubulin polymerization inhibitors based on pyrimidine ring skeletons (2023 · Bioorganic & Medicinal Chemistry Letters · 被引 10)